Beta-blocker tolerability in elderly heart failure patients

Hans-Dirk Düngen; Felix Mehrhof; Svetlana Apostolović; Simone Inkrot; Rainer Dietz

doi:10.1016/j.ijcard.2008.03.064

Beta-blocker tolerability in elderly heart failure patients

Int J Cardiol. 2009 Jul 24;136(1):93-4; author reply 94-5. doi: 10.1016/j.ijcard.2008.03.064. Epub 2008 Jul 7.

Authors

Hans-Dirk Düngen, Felix Mehrhof, Svetlana Apostolović, Simone Inkrot, Rainer Dietz

PMID: 18602708
DOI: 10.1016/j.ijcard.2008.03.064

Abstract

Beta-blocker therapy is well established for patients with chronic heart failure. In clinical practice, questions of tolerability and recommended target dose therapy remain important topics.

Publication types

Comment
Letter

MeSH terms

Adrenergic beta-Antagonists / adverse effects*
Adrenergic beta-Antagonists / pharmacokinetics
Adrenergic beta-Antagonists / therapeutic use
Age Factors
Aged
Clinical Trials as Topic / methods
Heart Failure / drug therapy*
Heart Failure / metabolism
Humans

Substances

Adrenergic beta-Antagonists